Twitter Linkedin Envelope

Industry partners

NATA is proud to partner with the following companies and thanks them for their support.

Platinum partner

vifor-pharma

Gold partner

werfen

Silver partners

CSLBehring_tagline_below_RGB_highres
HemoSonics is revolutionizing point-of-care bleeding management by bringing you the Quantra® Hemostasis Analyzer - a novel, closed-cartridge viscoelastic (VET) assay based on an innovative ultrasound technology. When time to treatment is critical, the Quantra System offers rapid, precise, and easy to interpret coagulation results that enable clinicians to make quick and informed bleeding management decisions in point-of-care (POC) settings such as the operating theatre or ICU. The Quantra System is both CE marked and FDA cleared for point-of-care use in perioperative patients 18 years or older. QPlus® cartridge is indicated for cardiovascular or major orthopedic surgery. QStat® cartridge is indicated for trauma or liver surgery (currently available outside of the US only). Because of its simple, intuitive, and safe POC workflow from sample collection to cartridge disposal, the Quantra is the first VET assay specifically indicated by FDA for point-of-care use. For more information, visit: www.HemoSonics.com/nata2021
i-SEP_Logotype-Couleur
Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and connectivity solutions. In 1995, Masimo debuted SET® Measure-through Motion and Low Perfusion™ pulse oximetry, estimated to be used on more than 100 million patients annually. In 2005, Masimo introduced rainbow® Pulse CO-Oximetry, allowing noninvasive and continuous monitoring of additional physiologic parameters that previously could only be measured invasively, such as total hemoglobin (SpHb®). We continue to advance noninvasive monitoring, connectivity, and automation with innovations like the Root® patient monitoring and connectivity hub and the Patient SafetyNet™ supplemental remote monitoring solution. For more information www.masimo.com
Pharmacosmos company profile At Pharmacosmos, we are specialists in iron therapy. We develop, manufacture and market medicines for the treatment of iron deficiency anaemia in humans and animals. We are furthermore specialists in developing and producing advanced carbohydrates for pharmaceutical and technical uses. Across the world, more than 1 billion people live with iron deficiency anaemia, making it one of the largest global health challenges of our time. At Pharmacosmos, we want to change the way iron deficiency is prevented and treated in humans and animals. We are inspired by one central question: How can we continue to improve patient safety, recovery and convenience and thereby achieve better outcomes? We seek the answer by staying at the scientific forefront of iron and carbohydrate technology – partnering with dedicated people and leading organisations to deliver the best possible treatments for human and veterinary use. In this way, we improve more than iron complexes and carbohydrates, we improve the quality of lives. We have our headquarters in Holbaek, Denmark and affiliates in the US, China, UK, Ireland, Germany, Denmark, Sweden and Norway. https://www.pharmacosmos.com/

SPONSORS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics visit http://www.haemonetics.com/en-gb/ https://www.linkedin.com/company/haemonetics https://twitter.com/HaemoneticsCorp https://www.facebook.com/HaemoneticsCorp
Medtronic logo
Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. Octapharma employs more than 10,000 people worldwide to support the treatment of patients in 118 countries with products across three therapeutic areas: haematology, immunotherapy and critical care. www.octapharma.fr
Pharmanutra logo
Sysmex supports healthcare professionals around the world in lighting the way with diagnostics by providing a broad range of medical diagnostics products and solutions. In the fields of haematology, urinalysis, haemostasis, oncology, flow cytometry and essential healthcare, we offer fully automated workflow solutions at a premium level, ensuring that we provide physicians and patients with options tailored to their specific needs. As a clinical value related to patient blood management, we offer tools to assess iron deficiency and bleeding risk. Sysmex Europe GmbH located near Hamburg, Germany is a subsidiary of the Sysmex Corporation in Kobe, Japan. From our Hamburg offices, we serve our affiliates, distributors and customers throughout Europe, the Middle East, and Africa (EMEA). For more information on how we are shaping the advancement of healthcare, visit www.sysmex-europe.com

NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis

MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals. 

Sitemap

Contact us

Follow us

Twitter Linkedin

SUBSCRIBE TO OUR NEWSLETTER

Consent Management Platform by Real Cookie Banner